Literature DB >> 12860759

The value of laparoscopic staging for patients with colorectal metastases.

Matthew S Metcalfe1, John S Close, Harish Iswariah, Charles Morrison, Simon A Wemyss-Holden, Guy J Maddern.   

Abstract

BACKGROUND: Resection offers the only chance of cure for hepatic colorectal metastases. However, preoperative staging does not always reliably detect unresectable disease. The aim of this study was to investigate the role that laparoscopy with ultrasound may have in detecting unresectable disease, thus sparing patients from unnecessary laparotomy with the associated morbidity and cost.
METHODS: A retrospective review of all patients considered for liver resection of colorectal metastases during a 3-year period was performed, analyzing factors likely to predict resectable disease, rates of resectability, and success of laparoscopic staging at detecting unresectable disease.
RESULTS: Of 73 patients with resectable disease on computed tomography, 24 were deemed to need laparoscopy, and 49 proceeded directly to laparotomy. Those first undergoing laparoscopy had shorter disease-free intervals between diagnosis of colorectal cancer and detection of hepatic recurrence and greater numbers of hepatic metastases. Twelve of the 24 patients who underwent laparoscopy had unresectable disease, and 8 of these were detected at laparoscopy. Forty-six of the 49 patients proceeding to laparotomy directly had resectable disease.
CONCLUSIONS: Laparoscopic staging of hepatic colorectal metastatic disease detects most unresectable disease, preventing unnecessary laparotomy. The likelihood of disease being unresectable is in part predicted by the disease-free interval and the number of hepatic metastases.

Entities:  

Mesh:

Year:  2003        PMID: 12860759     DOI: 10.1001/archsurg.138.7.770

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

1.  Clinical risk score can be used to select patients for staging laparoscopy and laparoscopic ultrasound for colorectal liver metastases.

Authors:  A J Shah; J Phull; M D Finch-Jones
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

3.  Surgical treatment of hepatic metastases from colorectal cancer.

Authors:  Georgios Tsoulfas; Manousos Georgios Pramateftakis; Ioannis Kanellos
Journal:  World J Gastrointest Oncol       Date:  2011-01-15

4.  A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.

Authors:  Daniel Jaeck; Elie Oussoultzoglou; Edoardo Rosso; Michel Greget; Jean-Christophe Weber; Philippe Bachellier
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

5.  Laparoscopic resection of hepatic colorectal metastases.

Authors:  Nicholas O'Rourke; Ian Shaw; Les Nathanson; Ian Martin; George Fielding
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

6.  Laparoscopic staging in selected patients with colorectal liver metastases as a prelude to liver resection.

Authors:  Sophie A Pilkington; Myrddin Rees; Delia Peppercorn; Timothy G John
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

7.  Metachronous liver metastases and resectability: Fong's score and laparoscopic evaluation.

Authors:  G Li Destri; F Di Benedetto; B Torrisi; T R Portale; F Mosca; R Vecchio; A Di Cataldo; S Puleo
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.